Advertisement

Journal of Endocrinological Investigation

, Volume 9, Issue 5, pp 367–370 | Cite as

A rat model of the 131I-induced changes in thyroid function

  • C. P. Reilly
  • R. G. Symons
  • M. L. Wellby
Article

Abstract

Thyrotoxic patients treated with lodine-131 (131I) often present with low thyroxine (T4), normal triiodothyronine (T3) and raised thyrotropin (TSH) concentrations in serum. We have developed a rat model of this low T4, raised TSH state. Rats were injected with 50, 150 or 450 μCi 131I. A dose of 50 μCi 131I caused no significant effect on thyroid function, as assessed by serum parameters whereas both 150 μCi and 450 μCi131I caused a significant fall in serum T4 concentration accompanied by a significant rise in TSH concentration. In all groups serum T3 concentration was not significantly altered when compared to controls. The clearance of 131I from the rats showed a single exponential curve (t 1/2 3.38 ± 0.61 days) over the range of 131I doses used. Differing body weights had no effect on the serum T4 changes induced by 131I.

Key-words

131I-Iodine treatment rat model 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bellabarba D., Bernard B., Langlois M. Pattern of serum thyroxine, triiodothyronine and thyrotropin after treatment of thyrotoxicosis. Clin. Endocrinol. (Oxf.) 1: 345, 1972.CrossRefGoogle Scholar
  2. 2.
    Sterling K., Brenner M.A., Newman -E.S., Odell W.D., Bellabarba D. The significance of triiodothyronine (T3) in maintenance of euthyroid status after treatment of hyperthyroidism. J. Clin. Endocrinol. Metab. 33: 729, 1971.PubMedCrossRefGoogle Scholar
  3. 3.
    Toft A.D., Irvine W.J., Seth J., Hunter W.M., Cameron E.H.D. Thyroid function in the long-term follow-up of patients treated with iodine-131 for thyrotoxicosis. Lancet 2: 576, 1975.PubMedCrossRefGoogle Scholar
  4. 4.
    Riesco G., Taurog A., Larsen P.R., Krulich L. Acute and Chronic Responses to Iodine Deficiency in Rats. Endocrinology 100: 303, 1977.PubMedCrossRefGoogle Scholar
  5. 5.
    Larsen P.R., Silva J.E., Kaplan M.M. Relationships between circulating and intracellular thyroid hormones: Physiological and Clinical Implications. Endocrinol. Rev. 2: 87, 1981.CrossRefGoogle Scholar
  6. 6.
    Lee W., Shleien B., Telles N.C., Chiaccierini R.P. An accurate method of 131I dosimetry in the rat thyroid. Radiat. Res. 79: 55, 1979.PubMedCrossRefGoogle Scholar
  7. 7.
    Book S.A., McNeill D.A., Parks N.J., Spangler W.L. Comparative effects of iodine-132 and iodine-131 in rat thyroid glands. Radiat. Res. 81: 246, 1980.PubMedCrossRefGoogle Scholar
  8. 8.
    van Best J.A. Dose calculations for 123I, 124I, 125I and 131I in the thyroid gland of the mouse, rat and man and comparison with thyroid function for mice and rats. Phys. Med. Biol. 26: 1035, 1981.PubMedCrossRefGoogle Scholar
  9. 9.
    van Doorn J., Roelfsema F., van der Heide D. The effect of propylthiouracil and methimazole on the peripheral conversion of thyroxine to 3, 5, 3′-triiodothyr-onine in athyreotic thyroxine-maintained rats. Acta Endocrinol. (Kbh.) 103: 509, 1983.Google Scholar
  10. 10.
    Silva J.E., Larsen P.R. Contributions of plasma triiodothyronine and local thyroxine monodeiodination to triiodothyronine to nuclear triiodothyronine receptor saturation in pituitary, liver and kidney of hypothyroid rats. Further evidence relating saturation of pituitary nuclear triiodothyronine receptors and the acute inhibition of thyroid-stimulating hormone release. J. Clin. Invest. 61: 6247, 1978.CrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 1986

Authors and Affiliations

  • C. P. Reilly
    • 1
  • R. G. Symons
    • 2
  • M. L. Wellby
    • 1
  1. 1.Department of Clinical ChemistryThe Queen Elizabeth HospitalWoodvilleAustralia
  2. 2.The Garvan Institute of Medical ResearchSt. Vincent’s HospitalDarlinghurstAustralia

Personalised recommendations